SIAG
TEVA icon

Safeguard Investment Advisory Group’s Teva Pharmaceuticals TEVA Stock Holding History

Safeguard Investment Advisory Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$410K Hold
12,094
– – 0.09% 102
2026
Q1 		$364K Sell
12,094
-396
-3% -$12.7K 0.1% 84
2025
Q4 		$390K Sell
12,490
-1,856
-13% -$45.7K 0.1% 85
2025
Q3 		$290K Sell
14,346
-157
-1% -$2.76K 0.07% 108
2025
Q2 		$243K Buy
14,503
+640
+5% +$10.3K 0.06% 120
2025
Q1 		$213K Buy
13,863
+4,352
+46% +$77.7K 0.06% 128
2024
Q4 		$210K Buy
+9,511
New +$173K 0.06% 106
2021
Q1 		– Sell
-4,388
Closed -$42K – 643
2020
Q4 		$42K Buy
+4,388
New +$42K 0.04% 220

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Safeguard Investment Advisory Group's TEVA Position: Q2 2026 in Review

Safeguard Investment Advisory Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 12,094 shares worth $410K. The position accounts for 0.09% of the portfolio, ranked #102.

Safeguard Investment Advisory Group first reported a position in TEVA in Q4 2020 and has held it in 8 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Safeguard Investment Advisory Group held 12,094 shares of Teva Pharmaceuticals worth $410K as of Q2 2026.
  • Safeguard Investment Advisory Group left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.09% of Safeguard Investment Advisory Group's portfolio in Q2 2026, its #102 holding.
  • Safeguard Investment Advisory Group first reported a position in Teva Pharmaceuticals in Q4 2020 and has held it in 8 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Safeguard Investment Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.